⌕
Sarepta Therapeutics · SRPT · Nasdaq
Tenet 48 · Mixed
Compare
$14.77−2.38%At closeTenet 48 · Mixed
$14.77−0.36 (−2.38%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD

Sarepta Therapeutics (SRPT) Stock Splits

Splits, dividend moves, buybacks and structural changes on file for SRPT, and what each one says about how management treats you, the shareholder.

Sources Dividend announcements and company filings Dividends and filingsHow we compute thisNot investment advice
•
Management posture
Returns cash, still building a record

Management returns cash through dividends and/or buybacks, but the track record is shorter or less consistent than a seasoned compounder's. Judge each action on its own coverage.

Annual raise streak
—
no dividend on file
Buyback · FY25
$27.4M
repurchased, latest FY
Last split
1:6
Jul 12, 2012 · reverse
Delist / distress
None
no red flags on file
Reads are interpretationsEach action's read is Tenet's plain-English interpretation of the action type: a starting point, not investment advice.

Reads are Tenet's plain-English interpretation of each action type, a starting point, not investment advice.

When did Sarepta Therapeutics last split its stock?

Sarepta Therapeutics' last split was 1:6 on Jul 12, 2012.

How much stock did Sarepta Therapeutics buy back last fiscal year?

Sarepta Therapeutics repurchased $27.4M of its own shares in fiscal 2025.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.